Global Anticoagulant Market 2017-2021

Table of Contents

PART 01: Executive summary 

PART 02: Scope of the report 

• Market overview 
• Top-vendor offerings 

PART 03: Market research methodology 

• Research methodology 
• Economic indicators 

PART 04: Introduction 

• Key market highlights 

PART 05: Disease overview 

PART 06: Pipeline analysis 

PART 07: Market landscape 

• Market overview 
• Five forces analysis 

PART 08: Market segmentation by ROA 

• Oral anticoagulants 
• Injectable anticoagulants 
• PART 09: Market segmentation by drug class 
• Factor Xa inhibitors 
• DTIs 
• Heparin 
• Vitamin K antagonists 

PART 10: Market segmentation by application 

• DVT 
• PE 
• AF 
• Others 

PART 11: Geographical segmentation 

• Global anticoagulant market in Americas 
• Anticoagulant market in EMEA 
• Anticoagulant market in APAC 

PART 12: Market drivers 

• Increasing demand for NOACs 
• Growing prevalence of coagulation disorders 
• Increase in hip and knee surgeries 

PART 13: Impact of drivers 

PART 14: Market challenges 

• Increasing cost of NOACs 
• Lack of antidotes in the market for NOACs 
• Patent expiry: a threat to market 

PART 15: Impact of drivers and challenges 

PART 16: Market trends 

• Strategic alliance 
• Increasing focus toward emerging economies 
• Patient assistance programs 

PART 17: Vendor landscape 

• Competitive scenario 
• Other prominent vendors 

PART 18: Key vendor analysis 

• Bayer HealthCare 
• Boehringer Ingelheim 
• Bristol-Myers Squibb 
• Daiichi Sankyo 
• Johnson & Johnson 
• Sanofi 

PART 19: Appendix 

• List of abbreviations 

PART 20: Explore Technavio